J. Griffith

发表

Koalas and climate change: a case study on the Liverpool Plains, north-west New South Wales

Crowther, W. Foley, I. Wallis, 2012 .

Absorption of enrofloxacin and marbofloxacin after oral and subcutaneous administration in diseased koalas (Phascolarctos cinereus).

M. Krockenberger, D. Higgins, M. Govendir, 2010, Journal of veterinary pharmacology and therapeutics.

A RETROSPECTIVE STUDY OF ADMISSION TRENDS OF KOALAS TO A REHABILITATION FACILITY OVER 30 YEARS

M. Krockenberger, N. Dhand, D. Higgins, 2013, Journal of wildlife diseases.

Evaluation of enrofloxacin use in koalas (Phascolarctos cinereus) via population pharmacokinetics and Monte Carlo simulation.

C. Landersdorfer, J. Bulitta, M. Govendir, 2014, Journal of veterinary pharmacology and therapeutics.

Plasma concentrations of chloramphenicol after subcutaneous administration to koalas (Phascolarctos cinereus) with chlamydiosis.

M. Krockenberger, J. Hanger, D. Higgins, 2012, Journal of veterinary pharmacology and therapeutics.

Subacute disseminated mucormycosis in a diabetic male.

R. Carter, S. Chapman, J. Griffith, 1989, The American journal of the medical sciences.

Clinical presentation, radiographic findings, and diagnostic methods of pulmonary blastomycosis: a review of 100 consecutive cases.

R. Carter, M. Petrini, J. Griffith, 1999, Southern medical journal.

Studies into the diagnosis, treatment and management of chlamydiosis in koalas

J. E. Griffith, J. Griffith, 2010 .

Acute miliary blastomycosis presenting as fluminating respiratory failure.

G. Campbell, J. Griffith, James E. Griffith, 1979, Chest.

Expression profiles of the immune genes CD4, CD8β, IFNγ, IL-4, IL-6 and IL-10 in mitogen-stimulated koala lymphocytes (Phascolarctos cinereus) by qRT-PCR

D. Higgins, J. Griffith, Q. Lau, 2014, PeerJ.

Pulmonary Actinomycosis in South Australian Koalas (Phascolarctos cinereus)

D. Trott, L. Woolford, D. McLelland, 2021, Veterinary pathology.

Pharmacokinetics of chloramphenicol following administration of intravenous and subcutaneous chloramphenicol sodium succinate, and subcutaneous chloramphenicol, to koalas (Phascolarctos cinereus).

M. Krockenberger, A. McLachlan, A. Gillett, 2013, Journal of veterinary pharmacology and therapeutics.

Diversity of MHC class II DAB1 in the koala (Phascolarctos cinereus)

M. Krockenberger, K. Belov, D. Higgins, 2012, Australian Journal of Zoology.

MHC class II diversity of koala (Phascolarctos cinereus) populations across their range

W. Jaratlerdsiri, J. Gongora, D. Higgins, 2014, Heredity.

Helminth communities of pademelons, Thylogale stigmatica and T. thetis from eastern Australia and Papua New Guinea.

N. Chilton, I. Beveridge, P. M. Johnson, 2000, Journal of helminthology.

Orchitis and Epididymitis in Koalas (Phascolarctos cinereus) Infected With Chlamydia pecorum

S. Johnston, A. Mckinnon, D. Higgins, 2015, Veterinary pathology.

Diagnosis, treatment and outcomes for koala chlamydiosis at a rehabilitation facility (1995-2005).

D P Higgins, D. Higgins, J E Griffith, 2012, Australian veterinary journal.

Within-population diversity of koala Chlamydophila pecorum at ompA VD1-VD3 and the ORF663 hypothetical gene.

D. Higgins, J. Griffith, T. Beninati, 2012, Veterinary microbiology.

Identification of MHCII variants associated with chlamydial disease in the koala (Phascolarctos cinereus)

D. Higgins, J. Griffith, Q. Lau, 2014, PeerJ.